Search our Innovation Portfolio

Appt Health is a digital platform that automates and personalises patient outreach to increase uptake in preventive care. In partnership with Imperial College London and seven Cancer Alliances, this NHS-funded project aims to improve cervical and lung cancer screening rates—particularly among underserved groups with historically lower attendance. The platform identifies eligible patients through integrated clinical systems, then sends tailored, behaviourally informed messages designed with local communities. By addressing barriers such as language, digital access, and awareness, Appt Health simplifies the booking process and supports earlier cancer diagnosis, helping practices reduce inequalities and meet national screening targets more effectively.

QP-Prostate® is a Software as a Medical Device (SaMD) designed to assist radiologists in reporting prostate MRI for patients suspected of having clinically significant prostate cancer (csPCa). Using T2w and DWI series from bpMRI/mpMRI studies, QP-Prostate® employs Artificial Intelligence (AI) to automatically identify and segment suspicious regions of interest (ROIs) for csPCa, providing confidence levels (High and Moderate) overlaid on axial T2w images for radiologist review. The software is trained and validated using biopsy outcomes (both targeted and systematic) as the ground truth, encompassing data from biopsy-naïve patients and those under active surveillance.

HELP Flag includes a laboratory-based alert for routine primary care blood tests that have high platelet counts, and provides an evidence-based pathway for GPs to triage patients with raised platelets.